Apr 10, 2024
Osler is proud to be ranked as the #1 law firm in the M&A league tables for Canada published by LSEG, Mergermarket and Bloomberg for the first quarter of 2024. According to LSEG, there was US$28 billion of deal activity with Canadian involvement announced in the first quarter. Osler advised on US$13.7 billion in total transaction value represented by 26 deals, including advising Fusion Pharmaceuticals in its acquisition by AstraZeneca; iCON Infrastructure in its investment in QSL; CDPQ on the sale of Plusgrade Inc., alongside Novacap to General Atlantic; and the Special Committee of Tricon Residential in its acquisition by Blackstone.
Highlights of Osler’s Q1 2024 rankings include:
- #1 law firm in M&A league tables for Canada for announced deals by value (LSEG, formerly Refinitiv)
- #1 law firm in M&A league tables for Canada for announced deals by value (Mergermarket)
- #1 law firm in M&A league tables for Canada for announced deals by value (Bloomberg)
Osler was also ranked as the #2 law firm in M&A league tables for Canada for announced deals by number of deals according to LSEG and Mergermarket. Jeremy Fraiberg, Co-Chair of Osler’s M&A group, was recently interviewed on the state of the Canadian market in The Globe and Mail.
With offices in Toronto, Montréal, Calgary, Ottawa, Vancouver and New York, Osler is consistently ranked among the leading M&A law firms in Canada. Our roles on domestic, cross-border and global transactions include advising public companies, private companies, portfolio companies, private equity sponsors, emerging and high growth companies, pension funds, sovereign funds, and financial advisors.
We invite you to learn more about our M&A practice and get in touch with a member of the team for more information about their work in this area of Canadian business.